NCT04662294View on ClinicalTrials.gov

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

January 15, 2024

Study Completion Date

January 15, 2027

Conditions
Acute Myeloid LeukemiaNon-hodgkin's LymphomaMultiple Myeloma
Interventions
BIOLOGICAL

CD70 CAR T-cells

Each subject receive CD70 CAR T-cells by intravenous infusion

Trial Locations (1)

310003

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER